Register or Sign in to Save this opportunity, or Send an Inquiry.
Phase I/II Drug for PHN
Cosmederm Bioscience Inc. United States flag United States
Abstract ID:
Cosmederm Bioscience has developed a family of small molecule compounds for topical treatment of inflammatory dermatological conditions and nerve pain
Send an Inquiry
RE:
Participants
You

Cosmederm Bioscience has a patented family of anti-itch, anti-inflammatory and anti-irritant small molecule compounds that can selectively suppress the symptoms of stinging, burning and itching and associated neurogenic inflammation in both keratinized skin and mucous membranes.

The technology is a potent anti-itch agent, and is a powerful inhibitor of inflammatory cytokines and neuropeptides such as TNF-α, IL-1α and IL-6.

The lead drug candidate, C746, is currently in a phase I/II trial with a targeted indication of PHN and or diabetic neuropathy.

A second candidate, C745, is preclinical and being developed for atopic dermatitis and/or general pruritus.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought
Licensing, joint development
FEATURED
Last Updated Nov 2014
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FINISHED PRODUCT
CORPORATION

Opportunity Contact


Warning: include(js_message_scripts_n2.php) [function.include]: failed to open stream: No such file or directory in /home/pharmalicensing/public_html/detail.php on line 833

Warning: include() [function.include]: Failed opening 'js_message_scripts_n2.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/pharmalicensing/public_html/detail.php on line 833